Search
Patexia Research
Case number 1:21-cv-01808

Allergan, Inc. v. Aurobindo Pharma Limited et al > Documents

Date Field Doc. No.Description (Pages)
Jul 27, 2022 35 Order (4)
Jul 27, 2022 35 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,858,961 B2. (Attachments: # (1) Order)(nms)
Jul 26, 2022 34 Order (4)
Docket Text: SO ORDERED Granting [33] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/26/2022. (nms)
Jul 22, 2022 33 Stipulation of Dismissal (4)
Docket Text: STIPULATION of Dismissal by Allergan, Inc.. (Tigan, Jeremy)
May 23, 2022 32 Notice of Service (1)
Docket Text: NOTICE OF SERVICE of 1) Defendants' Objections and Responses to Plaintiff Allergan's First Set of Interrogatories to Defendants (Nos. 1-12) and 2) Defendants' Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-28) filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited.(Ormerod, Eve)
Apr 22, 2022 31 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff Allergan, Inc.'s First Set of Interrogatories to Defendants (Nos. 1-12) and (2) Plaintiff Allergan's First Set of Requests for Production of Documents and Things to Defendants (Nos. 1-28) filed by Allergan, Inc..(Tigan, Jeremy)
Apr 18, 2022 30 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-9) and (2) Plaintiff's Objections and Responses to Defendants' First Set of Requests for Production (Nos. 1-41) filed by Allergan, Inc..(Tigan, Jeremy)
Mar 24, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Howard W. Levine for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Mar 23, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Katherine A. Helm for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Mar 18, 2022 29 Notice of Service (1)
Docket Text: NOTICE OF SERVICE of Defendants' 1) First Set of Interrogatories (Nos. 1-9), 2) First Set of Requests for Production (Nos. 1-41), and 3) Initial Invalidity Contentions filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited.(Ormerod, Eve)
Mar 7, 2022 28 Order (21)
Docket Text: SO ORDERED Granting [25] Stipulated Protective Order. Signed by Judge Richard G. Andrews on 3/7/2022. (nms)
Mar 7, 2022 27 Scheduling Order (10)
Docket Text: SCHEDULING ORDER: Joinder of Parties due by 7/15/2022. Amended Pleadings due by 7/15/2022. Joint Claim Construction Brief due by 11/29/2022. A Markman Hearing is set for 1/10/2023, at 9:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 3/7/2022. (nms)
Mar 4, 2022 26 Notice of Service (1)
Docket Text: NOTICE OF SERVICE of Defendants' core technical documents filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited.(Ormerod, Eve)
Mar 4, 2022 25 Proposed Order (21)
Docket Text: PROPOSED Stipulated Protective Order, by Allergan, Inc.. (Simonetti, Sarah) Modified on 3/7/2022 (nms).
Mar 4, 2022 24 Proposed Order (10)
Docket Text: PROPOSED Scheduling Order, by Allergan, Inc.. (Simonetti, Sarah) Modified on 3/4/2022 (nms).
Mar 3, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [23] STIPULATION and Proposed Order to Extend Time to submit proposed protective order to March 4, 2022. Signed by Judge Richard G. Andrews on 3/3/2022. (nms)
Mar 2, 2022 23 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION and Proposed Order to Extend Time to submit proposed protective order - filed by Allergan, Inc.. (Simonetti, Sarah) Modified on 3/3/2022 (nms).
Mar 2, 2022 22 Transcript (15)
Docket Text: Official Transcript of Teleconference held on 2/14/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/23/2022. Redacted Transcript Deadline set for 4/4/2022. Release of Transcript Restriction set for 5/31/2022. (Triozzi, Heather)
Feb 28, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [21] STIPULATION and Proposed Order to Extend Time to submit proposed protective order to March 2, 2022. Signed by Judge Richard G. Andrews on 2/28/2022. (nms)
Feb 25, 2022 21 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Allergan, Inc.. (Tigan, Jeremy) Modified on 2/28/2022 (nms).
Feb 24, 2022 20 Order (2)
Docket Text: SO ORDERED Granting [19] Stipulation and Proposed Order of Infringement of Claims 1-9 of the '961 Patent. Signed by Judge Richard G. Andrews on 2/24/2022. (nms)
Feb 23, 2022 19 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order of Infringement of Claims 1-9 of the '961 Patent by Allergan, Inc.. (Tigan, Jeremy)
Feb 23, 2022 18 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) and (2) Plaintiff's Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Allergan, Inc..(Tigan, Jeremy)
Feb 23, 2022 17 Notice of Service (1)
Docket Text: NOTICE OF SERVICE of Defendants Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A, Inc., and Eugia Pharma Specialties Ltd.'s Initial Disclosures and Paragraph 3 Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited.(Ormerod, Eve)
Feb 14, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Katherine A. Helm for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Feb 14, 2022 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 2/14/2022. Counsel for Plaintiff: J. Tigan. Counsel for Defendant: E. Ormerod. The parties are directed to resubmit the proposed scheduling order with the dates given during the telephone conference. (Court Reporter Heather Triozzi.) (lak)
Feb 11, 2022 16 Letter (1)
Docket Text: Letter to The Honorable Richard G. Andrews, from Sarah E. Simonetti, regarding dial-in for Rule 16 Conference. (Simonetti, Sarah) Modified on 2/11/2022 (nms).
Feb 10, 2022 15 Cover Letter to The Honorable Richard G. Andrews (1)
Feb 10, 2022 15 Main Document (13)
Docket Text: PROPOSED Scheduling Order, by Allergan, Inc.. (Attachments: # (1) Letter)(Simonetti, Sarah) Modified on 2/10/2022 (nms).
Feb 1, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Pejmon Pashai for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jan 31, 2022 14 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Howard W. Levine, Katherine A. Helm, and Pejmon Pashai - filed by Allergan, Inc.. (Tigan, Jeremy)
Jan 31, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney Howard W. Levine, Katherine A. Helm, and Pejmon Pashai, filed by Allergan, Inc.. Signed by Judge Richard G. Andrews on 1/31/2022. (nms)
Jan 28, 2022 13 Order Setting Scheduling Conference (1)
Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 2/14/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/28/2022. (nms)
Jan 27, 2022 12 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, Kenneth S. Canfield, Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited. (Belgam, Neal)
Jan 27, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Kenneth S. Canfield, Dmitry V. Shelhoff, Edward D. Pergament, Julia S. Kim for Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Eugia Pharma Specialties Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jan 27, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, Kenneth S. Canfield, Julia S. Kim, filed by Eugia Pharma Specialties Limited, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma Limited. Signed by Judge Richard G. Andrews on 1/27/2022. (nms)
Jan 25, 2022 11 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited. (Ormerod, Eve)
Jan 25, 2022 10 Answer to Complaint (8)
Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited.(Ormerod, Eve) Modified on 1/25/2022 (nms).
Jan 3, 2022 9 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Allergan, Inc.: For Eugia Pharma Specialties Limited waiver sent on 12/29/2021, answer due 2/28/2022. (Tigan, Jeremy)
Jan 3, 2022 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Allergan, Inc.: For Aurobindo Pharma U.S.A., Inc. waiver sent on 12/29/2021, answer due 2/28/2022. (Tigan, Jeremy)
Jan 3, 2022 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Allergan, Inc.: For Aurobindo Pharma Limited waiver sent on 12/29/2021, answer due 2/28/2022. (Tigan, Jeremy)
Dec 29, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Dec 23, 2021 1 Main Document (10)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3769838.) - filed by Allergan, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk)
Dec 23, 2021 6 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited on 12/23/2021; Aurobindo Pharma U.S.A., Inc. on 12/23/2021; Eugia Pharma Specialties Limited on 12/23/2021. (apk)
Dec 23, 2021 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan, Inc. filed by Allergan, Inc. (apk)
Dec 23, 2021 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,858,961 B2. (apk)
Dec 23, 2021 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/12/2021. Date of Expiration of Patent: 09/2/2023.Thirty Month Stay Deadline: 5/12/2024. (apk)
Dec 23, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
Dec 23, 2021 1 Civil Cover Sheet (2)
Dec 23, 2021 1 Exhibit A (17)
Dec 23, 2021 1 Complaint* (1)
Menu